On Sept. 28, the U.S. Food and Drug Administration (FDA) launched a user-friendly dashboard for its adverse event reporting system. The new dashboard enables…
According to Keith Hovey, an attorney at Szaferman, Lakind, Blumstein & Blader, speaking on behalf of the American Association of Nurse Attorneys, the New…
On Sept. 20, the U.S. Food and Drug Administration (FDA) cleared Pentax ED34-i10T, the first duodenoscope with a disposable distal cap, which will improve…
On Sept. 14, the U.S. Food and Drug Administration (FDA) approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple…
On Sept. 14, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular…
Missed nursing care because of inadequate staffing increases postoperative patients’ risk of dying within 30 days of hospital admission, according to a report in…
On Sept. 1, the U.S. Food and Drug Administration (FDA) approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid…
The Centers for Disease Control and Prevention has launched Get Ahead of Sepsis, an educational initiative to protect Americans from the devastating effects of…
“The FDA is committed to making new safe and effective antibacterial drugs available,” said Edward Cox, M.D., director of the Office of Antimicrobial Products…
Missed nursing care because of inadequate staffing increases postoperative patients’ risk of dying within 30 days of hospital admission, according to a…